lazertinib
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
1 FDA-registered drug labeler
Janssen Biotech, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Lazcluze
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Vendor Pricing
$1649.00/gAngene Chemical
CountryChina (registered: Hong Kong)
Pack$1649.00 / 1 g
Purity97%
Vendors15 available
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
14 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| Aaron Chemicals LLC | Hong Kong | $1804.00 | 250 mg | 97% |
| Combi-Blocks (back-ordered) | United States | $1980.00 | 250 mg | 95% |
| Molnova | China | $2070.00 | 500 mg | 99% |
| BLD Pharmatech Ltd. | China | $2232.00 | 250 mg | 97% |
| Ambeed, Inc. | United States | $2232.00 | 250 mg | 97% |
| A2B Chem LLC | United States | $2296.00 | 250 mg | 97% |
| AA BLOCKS | United States | $2540.00 | 250 mg | 97% |
| MedKoo Biosciences, Inc | United States | $2950.00 | 1 g | 98% |
| BLD Pharmatech Co., Limited | United States | $3280.00 | 100 mg | 97% |
| BLD Pharmatech GmbH | Germany | $3280.00 | 100 mg | 97% |
| MedChemExpress MCE | Sweden | $3450.92 | 500 mg | 99.87% |
| TargetMol Chemicals | China → United States | $3640.00 | 200 mg | 99.96% |
| Angene International Limited | United States | $3652.00 | 250 mg | 98% |
| Cayman Europe | Estonia | $15136.80 | 50 mg | 98% |
Chemical Identity
CAS1903008-80-9
PubChem CID121269225
DTXSIDDTXSID601376595
FormulaC30H34N8O3
Mol. Weight554.6 g/mol
SMILESCN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC
Data Sources
1212692252026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/lazertinib/cids/JSON
Archive: data/sources/pubchem_name/lazertinib.json
CAS 1903008-80-92026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json